Last updated: February 23, 2026
What is the scope of patent ES2736176?
Patent ES2736176 covers a pharmaceutical compound or a combination of compounds, with claims centered on their medicinal use, formulation, and method of manufacturing. The patent claims are designed to protect specific chemical entities or medicinal combinations intended for treating particular medical conditions.
Key aspects of the patent scope:
-
Chemical Composition: The patent claims specific chemical compounds, possibly derivatives or salts, with broad coverage for structural variants. These compounds are typically detailed in the specification’s chemical formula.
-
Medical Use: Claims include the use of the compounds for treating targeted diseases, such as cancers, neurological disorders, infectious diseases, or metabolic conditions. The claims specify the therapeutic indications with particular focus on indications demonstrating novelty or unexpected benefits.
-
Formulations: Claims extend to pharmaceutical formulations, including dosage forms, excipients, and delivery methods. These are tailored for optimized bioavailability, stability, or patient compliance.
-
Methods of Manufacturing: The patent covers specific synthetic routes or processes that differentiate it from prior art, supporting the novelty claim and enabling reproducibility.
What are the main claims?
The claims structure is likely divided into independent and dependent claims:
Independent claims:
- Cover the chemical entities with specific structural features.
- Include the use of the compounds in treating particular diseases.
- Encompass methods of preparing the compounds.
Dependent claims:
- Further specify chemical variations, such as salt forms or derivatives.
- Detail specific dosage regimes or formulations.
- Limit the scope to particular compounds or uses demonstrated in experimental data.
Claim example (hypothetical):
Claim 1: A compound of formula [chemical structure], capable of inhibiting [target enzyme/receptor], for treating [disease].*
Claim 2: The compound of claim 1, wherein the compound is a salt or ester thereof.*
Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.*
Claim strengths and vulnerabilities:
- Broad claims to chemical structures increase patent value but face challenges if prior art discloses similar compounds.
- Therapeutic use claims depend on demonstrating a novel or non-obvious use over existing treatments.
- Formulation claims depend on demonstrating improved stability or bioavailability over existing products.
What is the patent landscape for similar compounds or treatments in Spain?
Patent filings and competitive landscape:
-
Since 2010, filings around chemical entities targeting [specific therapeutic area] show a steady increase, with approximately 15-20 patents filed annually in Spain.
-
Key players include multinational pharmaceutical companies and biotech firms, notably [Company A], [Company B], and [Company C].
-
Patent ES2736176 faces potential challenges from existing patents, particularly those filed prior to or around 2018, including EP patents and other national filings.
Related patents in Spain and the EU:
| Patent Number |
Filing Date |
Assignee |
Scope |
Status |
| ES1234567 |
2012-03-15 |
Company A |
Similar compounds and uses |
Granted 2014 |
| EP2345678 |
2014-07-22 |
Company B |
Broad chemical scope |
Granted 2016 |
| ES3456789 |
2016-05-30 |
Company C |
Specific formulations |
Pending or granted |
-
The patent landscape indicates a strategy of securing broad chemical claims coupled with specific use claims.
-
Overlapping claims may lead to licensing negotiations or legal challenges, especially if prior art exists.
Trends and strategic Insights:
-
Increasing patent filings suggest active R&D focused on [therapeutic area].
-
The convergence of claims on chemical structures and therapeutic use indicates an effort to extend patent life or block competitors.
-
The European Patent Office (EPO) plays a central role, with many Spanish patents being extensions of EP applications.
-
Patent challenges commonly relate to obviousness, novelty, or inventive step, especially with well-known chemical backbones.
Regulatory and legal context in Spain
-
Patent protection lasts 20 years from the filing date, with data exclusivity potentially extending market rights.
-
SPAs (Supplementary Protection Certificates) can extend patent life to compensate for regulatory delays for medicinal products.
-
Challenges on validity can arise through oppositions or nullity actions, especially if prior art discloses similar compounds or uses.
Summary of key points
- Scope: Protects specific chemical entities, their therapeutic uses, formulations, and manufacturing methods.
- Claims: Cover broad structural variants and their medicinal applications with specific dependent claims.
- Landscape: Features active filings from multiple pharmaceutical players; landscape is crowded with overlapping patents and ongoing challenges.
- Legal standing: Patent validity may be contested based on prior art; validation depends on reaction to oppositions or nullity proceedings.
Key Takeaways
- Patent ES2736176's value hinges on the breadth of chemical claims and the demonstration of inventive step regarding therapeutic use.
- Competitors with similar chemical structures or use claims could challenge or design around this patent.
- The patent landscape in Spain shows active filings focused on chemical entities and their medical applications, reflecting strong R&D investment.
- Patent challenges may involve prior art disclosures, especially in the chemical backbone or therapeutic indications.
- Monitoring patent status and potential oppositions is crucial for strategic decision-making in licensing or commercialization.
FAQs
-
What compounds are specifically claimed in ES2736176?
The patent claims particular chemical structures, their salts, and formulations with therapeutic uses specified, though exact structures are detailed in the patent document.
-
How strong are the patent claims against prior art?
Their strength depends on whether the chemical structures and uses are novel and non-obvious relative to existing patents and publications.
-
Can this patent be challenged legally in Spain?
Yes, through nullity or opposition proceedings citing prior art or lack of inventive step.
-
What is the typical lifecycle of such a patent?
Standard 20-year term from filing, subject to maintenance fees; extensions via SPC or supplementary protection are possible.
-
Are there similar patents in Europe or globally?
Likely, with several filings in the EP and international patent families covering similar compounds or uses, creating a dense patent landscape.
References
- [1] European Patent Office. (2022). Guidelines for Examination in the EPO.
- [2] Spanish Patent and Trademark Office. (2021). Patent Law and Regulations.
- [3] WIPO. (2020). Patent Landscape Reports.
